News Conference News AHA 2017 Two FOURIER Subgroup Analyses Show Added Benefit of Evolocumab in Those With PAD, Prior MI Yael L. Maxwell November 13, 2017
News Conference News AHA 2017 CANTOS: Big Drop in CVD Events Among Canakinumab Responders Michael O'Riordan November 13, 2017
News Daily News PCSK9 Inhibitors: More Data Show Disappointing Approval Rates of Prescriptions by Payers Yael L. Maxwell October 30, 2017
News Daily News Statins and Diabetes: Causal Link Reinforced in New Analysis Michael O'Riordan October 25, 2017
News Daily News More CVD and Stroke Drive Shorter Life Spans in African-Americans: AHA Michael O'Riordan October 24, 2017
News Daily News Colchicine Stabilizes Plaque in ACS Patients, Imaging Study Suggests Michael O'Riordan October 20, 2017
News Daily News Evolocumab ‘Abjectly Fails’ Another Financial Stress Test Michael O'Riordan October 19, 2017
News Daily News CTA Reduces MI Compared With Functional Stress Testing, but at a Cost Michael O'Riordan October 05, 2017
News Daily News Quitting Chronic, Low-Dose Aspirin May Boost Risk of Cardiovascular Events Todd Neale September 25, 2017
News Daily News Secondary Prevention Lagging Behind in Women With Established Coronary Disease Todd Neale September 22, 2017
News Daily News Physical Activity of Any Ilk Cuts CVD, Deaths in Global Study: PURE Shelley Wood September 22, 2017
News Daily News Ischemic Heart Disease the Leading Cause of Death Globally Michael O'Riordan September 19, 2017
News Industry News New FOURIER Analysis Shows Repatha® (Evolocumab) Reduces Cardiovascular Events In Patients With Diabetes September 15, 2017
News Daily News Mobile Health Technologies May Boost Diagnosis, Care for Patients With Structural Heart Disease Yael L. Maxwell September 15, 2017
News Features COMPASS: All Signs Point to Big Impact in CAD and PAD, Experts Predict Todd Neale September 15, 2017
News Daily News Dust From World Trade Center Attacks Linked to Higher Lipid Levels in Children Yael L. Maxwell September 13, 2017
News Daily News ACC Updates Recommendations for Non-statin Therapy Use for LDL-Cholesterol Lowering in Secondary Prevention Yael L. Maxwell September 06, 2017